Baywater Healthcare, a Souter Investments portfolio company, has disposed of its market leading Irish business to Air Liquide for an undisclosed sum.
A leading homecare provider, Baywater Healthcare provides healthcare services to patients with long term conditions, including home oxygen therapy, nebuliser therapy, telehealth solutions, home ventilation support and home CPAP support for sleep apnoea.
Souter Investments backed the acquisition of Baywater Healthcare in 2013, in a Buy-In Management Buy-Out deal originated by Duke Street, the European mid-market private equity group. The Company is led by CEO Adam Sullivan, Finance Director Howard Jones and Chairman Douglas Quinn.
Baywater Healthcare will retain its UK business, serving around 28,000 patients, and has recently secured extensions to its major client contracts. The Company has an investment plan to accelerate its growth and expansion by targeting major new contracts coming to the market in the near future, in addition to pursuing other new business development opportunities in the UK.
About Baywater Healthcare
Baywater Healthcare is a leading homecare provider, serving approximately 28,000 patients and employing over 250 people in the UK. It is headquartered in Crewe.
The Company offers a range of respiratory therapies to patients in their homes including oxygen, nebuliser, continuous positive airway pressure (CPAP) and non-invasive ventilation, as well as monitoring patients and providing medical professionals with easy access to data with the potential to deliver wide-ranging benefits for clinicians, patients and the health service as a whole.
Baywater Healthcare’s services are contributing to a modern healthcare system by improving the patient’s quality of life and helping to reduce hospitalisations, co-morbidities and other secondary effects.
About Souter Investments
Souter Investments is the family investment office of Sir Brian Souter, co-founder and Chairman of Stagecoach Group plc. Souter Investments makes investments across a broad range of asset classes, with a primary focus on private equity; it also maintains allocations to other asset classes such as private equity funds, listed equities and property. Transport investments are made by Souter Investments’ sister company, Highland Global Transport.
In addition to Baywater Healthcare, Souter Investments unquoted holdings include stakes in another Duke Street deal, Voyage Care, the leading provider of support for people with learning difficulties, associated physical disabilities and complex needs; First Scottish Group, Scotland’s leading independent property, title and legal search provider; AMA Group, the Edinburgh based house builder and property developer; Mobius Life, a specialist investment administration platform and authorised unit-linked UK life insurance company; and Amerplast, the Finnish flexible packaging manufacturer.
Transport investments include New Zealand based urban bus operators Mana Coach Services, Howick and Eastern Buses and Reesby Buses; Auckland based ferry businesses Fullers Group and 360 Discovery; and long-distance express coach operators ManaBus.com and nakedbus.com. In Europe, Highland Global Transport holds stakes in intercity express coach operators PolskiBus.com, OnniBus.com and SuperBus.com, and in leading international bus and coach manufacturer Alexander Dennis.
Recent exits include the sale of luxury yacht manufacturer Sunseeker to Chinese conglomerate Dalian Wanda, the IPO of general insurer the esure Group on the London Stock Exchange and the sale of biofuel manufacturer Argent Energy to John Swire & Sons (Green Investments).
For more information please visit:
www.souterinvestments.com
www.highlandglobaltransport.com